Table 1 Baseline demographics, clinical presentation, VTE risk factors, PE risk stratification, VTE classification, DVT classification, PESI, and VTE onset
Variables | All patients N = 143 (%) | Survival N = 112 (%) | Death N = 31 (%) | |||
|---|---|---|---|---|---|---|
Age (years), mean ± SD | 58.5 ± 12.7 | 58.1 ± 13.6 | 60.0 ± 8.8 | |||
Gender (male) | 91 (63.6) | 70 (62.5) | 21 (67.7) | |||
BMI (kg/m2), mean ± SD | 30.9 ± 5.6 | 30.3 ± 5.6 | 31.6 ± 5.6 | |||
VTE Clinical presentation | ||||||
O2 saturation (%), mean ± SD | 87.9 ± 7.6 | 88.3 ± 7.4 | 85 ± 9.4 | |||
Sudden dyspnea | 31 (21.7) | 29 (25.9) | 2 (6.5) | |||
Progressive dyspnea | 26 (18.2) | 23 (20.5) | 3 (9.7) | |||
Pleuritic chest pain | 20 (14) | 19 (17) | 1 (3.2) | |||
Ischemic chest pain | 2 (1.4) | 2 (1.8) | 0 (0) | |||
Leg pain | 13 (9.1) | 11 (9.8) | 2 (6.5) | |||
Medical history and risk factors | ||||||
Hypertension | 50 (35) | 34 (30.4) | 16 (51.6) | |||
Diabetes | 33 (23.1) | 25 (22.3) | 8 (25.8) | |||
Lung disease | 16 (11.2) | 15 (13.4) | 1 (3.2) | |||
Medical history of cancer | 7 (4.9) | 5 (4.5) | 2 (6.5) | |||
Active cancer | 5 (3.5) | 3 (2.7) | 2 (6.5) | |||
Previous venous thromboembolism | 2 (1.4) | 2 (1.8) | 0 (0) | |||
In-hospital and ICU risk factors | ||||||
Immobilization | 88 (61.5) | 63 (56.3) | 25 (80.6) | |||
Sedation | 51 (35.7) | 27 (24.1) | 24 (77.4) | |||
Central venous lines | 52 (36.4) | 28 (25) | 24 (77.4) | |||
Vasopressors | 15 (10.5) | 4 (3.6) | 11 (35.5) | |||
PE risk stratification (ACC/AHA) | ||||||
Low risk | 24 (18.3) | 23 (20.5) | 1 (3.2) | |||
Submassive | 31 (23.7) | 29 (25.9) | 2 (6.5) | |||
Massive | 39 (29.8) | 21 (18.8) | 18 (58) | |||
Unable to classify | 37 (28.2) | 29 (25.9) | 8 (25.8) | |||
VTE classification | ||||||
Isolated pulmonary embolism | 112 (78.3) | 85 (75.9) | 27 (87.1) | |||
Isolated deep venous thrombosis | 12 (8.4) | 10 (8.9) | 2 (6.5) | |||
Pulmonary embolism plus DVT | 18 (12.6) | 16 (14.3) | 2 (6.5) | |||
Pulmonary embolism plus CVT | 1 (0.7) | 1 (0.9) | 0 (0) | |||
DVT classification | ||||||
Proximal DVT | 14 (9.8) | 11 (9.8) | 3 (9.7) | |||
Distal DVT | 5 (3.5) | 5 (4.5) | 0 (0) | |||
Proximal plus distal DVT | 5 (3.5) | 5 (4.5) | 0 (0) | |||
Upper limb DVT | 6 (4.2) | 4 (3.6) | 2 (6.5) | |||
Original PESI | ||||||
I (Very low risk) | 13 (9.1) | 13 (11.6) | 0 (0) | |||
II (Low risk) | 27 (18.9) | 25 (22.3) | 2 (6.5) | |||
III (Intermediate risk) | 45 (31.5) | 37 (33) | 8 (25.8) | |||
IV (High risk) | 11 (7.7) | 11 (9.8) | 0 (0) | |||
V (Very high risk) | 35 (24.5) | 19 (17) | 16 (51.6) | |||
VTE onset | ||||||
Home | 53 (37.1) | 48 (42.9) | 5 (16.1) | |||
In-hospital | 90 (62.9) | 64 (57.1) | 26 (83.9) | |||